Clinical Trial

A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project is designed to evaluate the efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious uveitis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-10-23; most recent amendment 2024-07-01.
Trial Details
NCT Number NCT05592717
Lead Sponsor Tianjin Medical University
Conditions Uveitis, YUTIQ
Enrollment 15 participants
Start Date 2023-01-05
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-03